Insulet
PODD
#2139
Rank
NZ$16.18 B
Marketcap
NZ$233.43
Share price
0.13%
Change (1 day)
-55.98%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

EPS for Insulet (PODD)

EPS in 2026 (TTM): NZ$7.34

According to Insulet's latest financial reports the company's current EPS (TTM) is NZ$7.56. In 2024 the company made an earnings per share (EPS) of NZ$10.69 an increase over its 2023 EPS that were of NZ$5.27.

EPS history for Insulet from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$7.34
2024NZ$10.69102.71%
2023NZ$5.274114.29%
2022NZ$0.13-69.57%
2021NZ$0.41109.09%
2020NZ$0.20-38.89%
2019NZ$0.32200%
2018NZ$0.11-113.04%
2017NZ-$0.82-9.8%
2016NZ-$0.91-60.47%
2015NZ-$2.3038.71%
2014NZ-$1.6612.05%
2013NZ-$1.48-23.15%
2012NZ-$1.93-12.2%
2011NZ-$2.20

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$15.61 106.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$5.57-26.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
NZ$7.29-3.55%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Eli Lilly
LLY
NZ$53.40 606.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Tandem Diabetes Care
TNDM
NZ-$1.66-121.99%๐Ÿ‡บ๐Ÿ‡ธ USA
ICU Medical
ICUI
NZ$2.14-71.63%๐Ÿ‡บ๐Ÿ‡ธ USA
DexCom
DXCM
NZ$4.63-38.77%๐Ÿ‡บ๐Ÿ‡ธ USA